Mylan N.V. Separation Agreements
6 Contracts & Agreements
- Amendment No. 4 to the Separation and Distribution Agreement, dated as of November 15, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 19, 2020)
- Separation Agreement, entered into on August 5, 2020, by and between Mylan Inc. and Kenneth Parks (Filed With SEC on November 6, 2020)
- Amendment No. 3, dated as of September 18, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on November 6, 2020)
- Amendment No. 2, dated as of May 29, 2020, to the Separation and Distribution Agreement, dated as of July 29, 2019, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on June 1, 2020)
- Amendment No. 1 to the Separation and Distribution Agreement, dated as of February 18, 2020, by and between Pfizer Inc. and Upjohn Inc (Filed With SEC on May 11, 2020)
- Separation and Distribution Agreement, dated as of July 29, 2019, by and among Pfizer Inc. and Upjohn Inc (Filed With SEC on July 29, 2019)
